Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06576830 · ClinicalTrials.gov registry record · Phase 4

Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia

A Phase 4 study of Pain, Postoperative and Sleep Disordered Breathing, sponsored by Duke University.

Recruiting
Registry status
Phase 4
Development phase
440
Enrollment target
1
Study location

NCT06576830 is a Phase 4 study of Pain, Postoperative and Sleep Disordered Breathing that is actively recruiting participants, run by Duke University. The registered enrollment target is 440 participants, above the 269-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06576830, a Phase 4 study of Pain, Postoperative and Sleep Disordered Breathing, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
Phase 4
Development phase
440 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery in children and adolescents.

Interventions

  • DRUG Methadone
  • DRUG Fentanyl/Hydromorphone

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2024-11-21
Est. Completion 2029-06-01
Phase Phase 4

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06576830

The ClinicalTrials.gov registry entry for NCT06576830 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 269-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (64% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Methadone is the first listed.

NCT06576830 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06576830 about?

NCT06576830 is a clinical study titled "Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia". The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery in children and adolescents.

What is the current status of trial NCT06576830?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 440 participants. The study started on 2024-11-21. Estimated completion is 2029-06-01.

What conditions does trial NCT06576830 study?

This clinical trial studies the following conditions: Pain, Postoperative, Sleep Disordered Breathing, Tonsillitis, Tonsillar Hypertrophy, Pediatric Sleep Apnea.

What interventions are being tested in trial NCT06576830?

The interventions under investigation include: Methadone (DRUG), Fentanyl/Hydromorphone (DRUG).

Who is sponsoring clinical trial NCT06576830?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06576830 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.